Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 15.0 | 59 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.0 | 71 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 13.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.0 | 52 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 13.0 | 64 | |
RA2159 | 3 | IL2-Ra | 14.5 | 50 | |||||||
N2586 | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 12.5 | 74 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.0 | 58 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.5 | 72 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.5 | 46 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 3 | IL2-Ra | 14.0 | 59 | |
N2586 | 3 | IL2-Ra | 17.0 | 53 | |||||||
RA2159 | EGF | 100 | ng/mL | 3 | IL2-Ra | 13.0 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 12.5 | 50 | |
RA2159 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 15.0 | 51 | |
RA2159 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 13.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 14.0 | 64 | |
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 11.0 | 54 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 3 | IL2-Ra | 13.0 | 54 | ||||
N2586 | EGF | 100 | ng/mL | 3 | IL2-Ra | 15.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 12.0 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 18.0 | 61 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 19.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 3 | IL2-Ra | 14.0 | 78 |